<p>Syndax Pharmaceuticals Inc. has amended its bylaws to provide that, beginning December 18, 2025, all shares of the company’s capital stock will be issued solely in uncertificated form. Shares represented by certificates issued before this date will remain in certificated form until the certificates are surrendered to the company. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syndax Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-326961), on December 19, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

SNDX

<p>Syndax Pharmaceuticals Inc. has amended its bylaws to issue all shares in uncertificated form starting December 18, 2025. Existing certificated shares will remain so until surrendered. This change was announced via EDGAR by the U.S. SEC. The information is for informational purposes and not financial advice.</p>

Syndax Pharmaceuticals Moves to Uncertificated Shares